# Premarket Notification [510(k)] Summary

This summary of $5 1 0 ( \mathbf { k } )$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

The assigned 510(k) number is : k123171

Company: Horiba ABX SAS Parc Euromédecine Rue du Caducée - BP 7290 34184 Montpellier cedex 4 FRANCE Telephone: + (33) 4 67 14 18 43 Fax: + (33) 4 67 14 15 17

Contact Person: Caroline Ferrer (caroline.ferrer@horiba.com)

Date Prepared: $0 2 ^ { \mathfrak { n } \mathfrak { d } }$ July, 2013

# A. Device Names:

The following reagent, controls & calibrators are for use in conjunction with the ABX PENTRA 400 instrument, cleared to market under K052007.

# REAGENTS :

# ABX PENTRA CALCIUM AS CP

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Calcium Arsenazo   
Class II   
$\ S 8 6 2 . 1 1 4 5$ : Calcium test system   
CJY: Azo Dye, Calcium

# CALIBRATORS:

ABX PENTRA Multical (Already cleared to market under K052007)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Multical $\cdot$   
Class II   
$\ S 8 6 2 . 1 1 5 0 : \mathbf { C a l i b r a t o }$ r   
JIX ; Calibrator, Multi-Analyte Mixture

ABX PENTRA N Control (Aready cleared to market under K052007)

CONTROLS :   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
N Control   
Class I   
§862.1660 : Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed)

# ABX PENTRA P Control (Already cleared to market under K052007)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
P Control   
Class I   
$\ S 8 6 2 . 1 6 6 0$ : Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (assayed)

# ABX PENTRA Urine Control L/H (Already cleared to market

Trade/Proprietary Name:   
under K070249)   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Urine control   
Class I   
$\ S 8 6 2 . 1 6 6 0$ : Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed)

# B. Substantial Equivalence:

The data and information supplied in this submission demonstrates substantial equivalence to their respective predicate devices:

<table><tr><td rowspan=1 colspan=1>Submission device</td><td rowspan=1 colspan=1>Substantially equivalentPredicate device</td></tr><tr><td rowspan=1 colspan=1>ABX Pentra Calcium AS CP</td><td rowspan=1 colspan=1>K061575</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX Pentra Multical</td><td rowspan=1 colspan=1>K052007</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX Pentra N Control</td><td rowspan=1 colspan=1>K052007</td></tr><tr><td rowspan=1 colspan=1>ABX Pentra P Control</td><td rowspan=1 colspan=1>K052007</td></tr><tr><td rowspan=1 colspan=1>ABX Pentra Urine Control L/H</td><td rowspan=1 colspan=1>K070249</td></tr></table>

# 1.Comparison of new device (ABX Pentra Calcium AS CP ) with the predicate device (Olympus Calcium Arsenazo reagent):

Similarities :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K061575):</td><td colspan="1" rowspan="1">New Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Olympus Calcium Arsenazoreagent</td><td colspan="1" rowspan="1">ABX Pentra Calcium AS CP</td></tr><tr><td colspan="1" rowspan="1">Indications for use</td><td colspan="1" rowspan="1">Olympus Calcium Arsenazoreagent is a diagnostic reagent forquantitative in vitro determinationof calcium in human serum, plasmaand urine by colorimetry.Measurement of calcium is used inthe diagnosis and treatment ofparathyroid disease, a variety ofbone diseases, chronic renal diseaseand tetany (intermittent muscularcontractions or spasms).</td><td colspan="1" rowspan="1">Identical</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">Calcium</td><td colspan="2" rowspan="1">Identical</td></tr><tr><td colspan="1" rowspan="1">Method</td><td colspan="1" rowspan="1">Calcium ions (Ca2+) react withArsenazo III (2,2'-[1,8-Dihydroxy-3,6-disulphonaphthylene-2,7-bisazo]- bisbenzenearsonic acid) toform an intense purple colouredcomplex. The absorbance of theCa-Arsenazo III complex ismeasured bichromatically at660/700 nm. The resulting increasein absorbance of the reactionmixture is directly proportional tothe calcium concentration in thesample.</td><td colspan="2" rowspan="1">Identical</td></tr><tr><td colspan="1" rowspan="1">Specimen</td><td colspan="1" rowspan="1">Serum, plasma and urine</td><td colspan="2" rowspan="1">Identical</td></tr><tr><td colspan="1" rowspan="1">Closed reagentstability</td><td colspan="1" rowspan="1">Until the expiration date printed onthe label when stored at 2-8°C</td><td colspan="2" rowspan="1">Identical</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Liquid</td><td colspan="1" rowspan="1">Identical</td><td colspan="1" rowspan="1">canmaGelow</td></tr></table>

# Differences :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K061575):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Olympus Calcium Arsenazoreagent</td><td colspan="1" rowspan="1">ABX Pentra Calcium AS CP</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Olympus Corp /Beckman Coulter</td><td colspan="1" rowspan="1">HORIBA ABX SAS, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Clinical chemistry analyzer</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Mono reagent bottle, ready to use.Final reactive ingredient: ArsenazoIII</td><td colspan="1" rowspan="1">Mono reagent cassette, readyto use.Final reactive ingredient:Identical</td></tr><tr><td colspan="1" rowspan="1">Label</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Horiba Medical specific label</td></tr><tr><td colspan="1" rowspan="1">Notice</td><td colspan="1" rowspan="1">Beckman Coulter specific notice</td><td colspan="1" rowspan="1">Horiba Medical specific notice</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Mono reagent bottleREAGENT: 4 x15 ml</td><td colspan="1" rowspan="1">Mono-reagent cassette :REAGENT : 1x79 ml</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Commercially available qualitycontrol material (not included):Controls Cat. No.ODC0003 andODC0004 for serum/plasma.Biorad Liquichek Urine ChemistryControls Cat. No. 397 and 398 forurine.</td><td colspan="1" rowspan="1">Recommended quality controlmaterial (not included):ABX Pentra N Control andABX Pentra P Control forserum /plasma.ABX Pentra Urine ControlL/H for urine.</td></tr><tr><td colspan="1" rowspan="1">Calibrators</td><td colspan="1" rowspan="1">Commercially available calibrator(not included):System Calibrator Cat. No. 66300for serum/plasma application andUrine Calibrator Cat. No.ODC0025 for urine</td><td colspan="1" rowspan="1">Recommended calibrationmaterial (not included):ABX Pentra Multical</td></tr><tr><td colspan="1" rowspan="1">Open Reagentstability</td><td colspan="1" rowspan="1">Once open, reagent stored on boardthe instrument is stable for 90 days.</td><td colspan="1" rowspan="1">Once opened, the reagentcassette placed in theinstrument (refrigerated</td></tr><tr><td></td><td></td><td>compartiment at 2-8°C) is stable for 60 days</td></tr></table>

2Comparison of new device (ABX Pentra MULTICAL) with the predicate device (ABX Pentra MULTICAL already cleared to market under K052007):

The ABX Pentra MULTICAL was previously described and cleared by the FDA under K052007 and the following submissions K062737, K060205, K062180, K060854, K060434, K072115, K110137, K110530.

However we have added it in this submission, as it is used in combination with a parameter. The only difference between the previously cleared calibrator and the ones incluided in this submission is the parameter calibrated submitted to the FDA.

# Similarities :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K052007):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra MULTICAL</td><td colspan="1" rowspan="1">ABX PentraMULTICAL</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Roche</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Commercialized by</td><td colspan="1" rowspan="1">HORIBA ABX SAS, France</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">ABX PENTRA 400</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Calibration of HORIBA Medical methods onclinical chemistry analyzers</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">-Vial (lyophilizate)-Human serum with chemical additives and tissueextracts of human and animal origin</td><td colspan="1" rowspan="1">nchanged</td></tr><tr><td colspan="1" rowspan="1">Biological additives</td><td colspan="1" rowspan="1">ALT (GPT), AST (GOT), Albumin, Aldolase,Alkaline phosphatase, Amylase total, PancreaticAmylase, Cholesterol, Cholinesterase, CreatineKinase, Gamma-GT, GLDH, LD (LDH), Lipase,Acid phosphatase, Total proteins</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilizate (to reconstitute with distilled/deionisedwater — not provided)</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">Horiba Medical specific label</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Notice</td><td colspan="1" rowspan="1">Horiba Medical specific notice</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Kit composed of :10 x bottle, each with lyophilizate for 3 mlcalibrator</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Calibration values</td><td colspan="1" rowspan="1">Determined using parameter-specificmethods (mentioned in the annex) under strictlystandardized conditions on HORIBA Medical</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">analyzers using HORIBA Medical system reagentsand HOR1BA Medical master calibratorThe calibration value specified is the medianof the values obtainedThe assigned values are indicated in theannex enclosed in the kitThe values are lot-specific.</td><td colspan="1" rowspan="1">−</td></tr><tr><td colspan="1" rowspan="1">Performance data :Closed stability</td><td colspan="1" rowspan="1">24 months at 2-8°C</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Components** stabilityafter reconstitution of thecalibrator</td><td colspan="1" rowspan="1">At 15 to 25°C : 8 hoursAt 2 to 8°C: 2 daysAt 25°C to -15°C: 2 weeks (when frozen once)**Exceptions:Stability of Direct BilirubinAt 15 to 25°C: 3 hoursAt 2 to 8°C: 8 hoursAt 25°C to -15°C: 2 weeks (when frozen once)Stability of Total BilirubinAt 15 to 25°C: 6 hoursAt 2 to 8°C: 1 dayAt -25°C to -15°C: 2 weeks (when frozen once)</td><td colspan="1" rowspan="1">Unchanged</td></tr></table>

Differences :

<table><tr><td rowspan=1 colspan=1>Device (K052007):</td><td rowspan=1 colspan=1>Device:</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>ABX Pentra MULTICAL</td><td rowspan=1 colspan=1>ABX PentraMULTICAL</td></tr><tr><td rowspan=1 colspan=1>Calibrated molecules</td><td rowspan=1 colspan=1>The exact calibrator values aregiven in the enclosed annex</td><td rowspan=1 colspan=1>Updated toinclude newapplicationvalues for newarsenazo calcium</td></tr><tr><td rowspan=1 colspan=1>Calibrated molecules: ALP, ALT,Amylase, AST, Creatine kinase, GGT,Lipase, Albumin, Direct Bilirubin, TotalBilirubin, Calcium, Cholesterol,Creatinine 120, Glucose HK, GlucosePAP, Iron, Lactic Acid, Magnesium,Phosphorus, Total Protein, Total protein100, Triglyverides, Urea/BUN, Uric acid,Enzymatic Creatinine, New ArsenazoCalcium</td><td rowspan=1 colspan=1>Applications cleared K060205CLIA K062180 K06318 K062737CLIA CLIA K060434 K060325K060325 K060205 K060854K072115 - K062007 K062007K060505 CLIA K060205K060205 K060434 K072115K060854 K060205 K060205K110137 K110530</td><td rowspan=1 colspan=1>NewArsenazoCalciumApplication notcleared (in thissmssion)</td></tr><tr><td rowspan=1 colspan=1>Value sheet/Annex</td><td rowspan=1 colspan=1>Horiba Medical specific annex</td><td rowspan=1 colspan=1>New HoribaMedical specificannex</td></tr></table>

3.Comparison of new device (ABX Pentra N CONTROL) with the predicate device (ABX Pentra N CONTROL already cleared to market under K052007):

The ABX Pentra N CONTROL was previously described and cleared by the FDA under K052007 and the following submissions K062737, K060205, K060318, K060325, K062180, K060854, K060434, K072115, K110137, K110530.

However we have added it in this submission, as it is used in combination with a parameter. The only difference between the previously cleared control and the ones included in this submission is the parameter controlled submitted to the FDA.

# Similarities :

<table><tr><td colspan="1" rowspan="1">E</td><td colspan="1" rowspan="1">Predicate device (K052007):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra N Control</td><td colspan="1" rowspan="1">ABX PentraN Control</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Roche</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Commercialized by</td><td colspan="1" rowspan="1">HORIBA ABX SAS, France</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">ABX PENTRA 400</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">- Quality control by monitoring accuracy and precisionfor the quantitative methods as specified in theenclosed value sheetConcentrations and activities are mostly in thenormal or near-normal range</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">-Vial (lyophilizate)-Human serum with chemical additives and tissueextracts of human and animal origin</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Biological additives</td><td colspan="1" rowspan="1">ALT (GPT), AST (GOT), Albumin, Aldolase,Alkaline phosphatase, Amylase total, PancreaticAmylase, Cholesterol, Cholinesterase, CreatineKinase, Gamma-GT, GLDH, LD (LDH), Lipase, Acidphosphatase, Total proteins</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilizate (to reconstitute with distilled/deionisedwater — not provided)</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">Horiba Medical specific label</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Notice</td><td colspan="1" rowspan="1">Horiba Medical specific notice</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Kit composed of :10 x bottle, each with lyophilizate for 5 ml control</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Theoretical values andconfidence intervals</td><td colspan="1" rowspan="1">- The theoretical value specified is the median of thevalues obtained, the confidence interval equals thetheoretical value ± 3SD (SD = Standard</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Deviation- The assigned values are indicated in the annexenclosed in the kit.-The values are lot-specific.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Performance data :Closed stability</td><td colspan="1" rowspan="1">30 months at 2-8°C</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Components** stabilityafter reconstitution ofthe control</td><td colspan="1" rowspan="1">At 15-25°C :12 hoursAt 2-8°C : 5 daysAt (-15°C) - (-25°C) : 4 weeks (when frozen once)**Exceptions:Stability of Total BilirubinAt 15-25°C : 8 hoursAt 2 - 8°C : 24 hoursAt (-15°C)- (-25°C) :2 weeks (when frozen once)Stability of Direct BilirubinAt 15 - 25°C : 4hoursAt 2 - 8°C : 8 hoursAt (-15°C) - (-25°C) :2 weeks (when frozen once)</td><td colspan="1" rowspan="1">Unchanged</td></tr></table>

# Differences :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K052007):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra N Control</td><td colspan="1" rowspan="1">ABX Pentra NControl</td></tr><tr><td colspan="1" rowspan="1">Controlled molecules</td><td colspan="1" rowspan="1">The exact control values are given in theenclosed annex</td><td colspan="1" rowspan="1">Updated toinclude newapplicationvalues for newarsenazocalcium</td></tr><tr><td colspan="1" rowspan="1">Controlled molecules :</td><td colspan="1" rowspan="1">Applications cleared :</td><td colspan="1" rowspan="1">Application notcleared underthis submission:</td></tr><tr><td colspan="1" rowspan="1">ALP, ALT, Amylase, AST, Creatinekinase, GGT, Lipase, Albumin, DirectBilirubin, Total Bilirubin, Calcium,Chloride, Cholesterol, HDL, LDL,Creatinine 120, Glucose HK, GlucosePAP, Iron, Lactic Acid, Magnesium,Phosphorus, Potassium, Sodium,Total Protein, Total Protein 100,Triglycerides. Urea/BUN, Uric acid,Enzymatic Creatinine, new arsenazocalcium</td><td colspan="1" rowspan="1">K060205, CLIA, K062180, K06318,K062737, CLIA, CLIA, K060434,K060325, K060325, K060205,K052007, K060854, K060854,K060854, K072115,K052007,K052007, K060205, CLIA, K060205,K060205, K052007, K052007,K060434, K072115, K060854,K060205, K060205, K110137K110530, - .</td><td colspan="1" rowspan="1">- NewarsenazocalciumApplication notcleared (in thissubmission</td></tr><tr><td colspan="1" rowspan="1">Value sheet / Annex</td><td colspan="1" rowspan="1">Horiba Medical specific annex</td><td colspan="1" rowspan="1">New HoribaMedical</td></tr><tr><td></td><td></td><td>specific annex</td></tr><tr><td></td><td></td><td></td></tr></table>

4. Comparison of new device (ABX Pentra P CONTROL) with the predicate device (ABX Pentra P CONTROL already cleared to market under K052007):

The ABX Pentra P CONTROL was previously described and cleared by the FDA under K052007 and the following submissions K062737, K060205, K060318, K060325, K062180, K060854, K060434, K072115, K110137, K110530.

However we have added it in this submission, as it is used in combination with a parameter. The only difference between the previously cleared control and the ones included in this submission is the parameter controlled submitted to the FDA.

# Similarities :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K052007):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra P Control</td><td colspan="1" rowspan="1">ABX PentraControl</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Roche</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Commercialized by</td><td colspan="1" rowspan="1">HORIBA ABX SAS, France</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">ABX PENTRA 400</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Quality control by monitoring accuracy and precisionfor the quantitative methods as specified in the enclosedvalue sheetConcentrations and activities are mostly in the normalor near-normal range</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Vial (lyophilizate)Human serum with chemical additives and tissueextracts of human and animal origin</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Biological additives</td><td colspan="1" rowspan="1">ALT (GPT), AST (GOT), Albumin, Aldolase, Alkalinephosphatase, Amylase total, Amylase Pancreatic,Cholesterol, Cholinesterase, Creatine Kinase, Gamma-GT, GLDH, LD (LDH), Lipase, Acid phosphatase,Total proteins</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilizate (to reconstitute with distilled/deionisedwater — not provided)</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">Horiba Medical specific label</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Notice</td><td colspan="1" rowspan="1">Horiba Medical specific notice</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Kit composed of :10 x bottle, each with lyophilizate for 5 ml control</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Theoretical values and</td><td colspan="1" rowspan="1">The theoretical value specified is the median of thevalues obtained, the confidence interval equals the</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">confidence intervals</td><td colspan="1" rowspan="1">theoretical value ± 3SD (SD = Standard Deviation)- The assigned values are indicated in the annexenclosed in the kit.-The values are lot-specific.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Performance data :Closed stability</td><td colspan="1" rowspan="1">30 months at 2-8°C.</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Components** stabilityafter reconstitution ofthe control</td><td colspan="1" rowspan="1">At 15-25°C :12 hours At 2-8°C : 5 daysAt (-15°C) - (-25°C) : 1 month (when frozen once)**Exceptions:Stability of Total BilirubinAt 15-25°C : 8 hoursAt 2 - 8°C : 24 hoursAt (-15°C)- (-25°C) :2 weeks (when frozen once)Stability of Direct BilirubinAt 15 - 25°C : 4hoursAt 2 - 8°C : 8 hoursAt (-15°C) - (-25°C) :2 weeks (when frozen once)</td><td colspan="1" rowspan="1">Unchanged</td></tr></table>

Differences :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K052007):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra P Control</td><td colspan="1" rowspan="1">ABX Pentra PControl</td></tr><tr><td colspan="1" rowspan="1">Controlled molecules</td><td colspan="1" rowspan="1">The exact control values are given in theenclosed annex</td><td colspan="1" rowspan="1">Updated toinclude newapplicationvalues for newarsenazocalcium</td></tr><tr><td colspan="1" rowspan="1">Controlled molecules :</td><td colspan="1" rowspan="1">Applications cleared :</td><td colspan="1" rowspan="1">Application notcleared underthissubmission:</td></tr><tr><td colspan="1" rowspan="1">ALP, ALT, Amylase, AST, Creatinekinase, GGT, Lipase, Albumin, DirectBilirubin, Total Bilirubin, Calcium,Chloride, Cholesterol, HDL, LDL,Creatinine 120, Glucose HK, GlucosePAP, Iron, Lactic Acid, Magnesium,Phosphorus, Potassium, Sodium,Total Protein, Total Protein 100,Triglycerides, Urea/BUN, Uric acid,Enzymatic Creatinine, New arsenazocalcium</td><td colspan="1" rowspan="1">K060205, CLIA, K062180, K06318,K062737, CLIA, CLIA, K060434,K060325, K060325, K060205,K052007, K060854, K060854,K060854, K072115,K052007,K052007, K060205, CLIA, K060205,K060205, K052007, K052007,K060434, K072115, K060854,K060205, K060205, K110137 K110530</td><td colspan="1" rowspan="1">New arsenazocalciumApplication notcleared (in thissubmission)</td></tr><tr><td>Value sheet / Annex</td><td>Horiba Medical specific annex</td><td>New Horiba Medical specific annex</td></tr></table>

5. Comparison of new device (ABX Pentra URINE CONTROL L/H) with the predicate device (ABX Pentra URINE CONTROL L/H already cleared to market under K070249):

The ABX Pentra URINE CONTROL L/H was previously described and cleared by the FDA under K070249 and the following submission K0721 15, K1 10137, K1 10530.

However we have added it in this submission, as it is used in combination with a parameter. The only difference between the previously cleared control and the ones included in this submission is the parameter controlled submitted to the FDA.

# Similarities :

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (K070249):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">ABX Pentra Urine Control L/H</td><td colspan="1" rowspan="1">ABX PentraUrine ControlL/H</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Biorad</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Commercialized by</td><td colspan="1" rowspan="1">HORIBA ABX SAS, France</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">ABX PENTRA 400</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Quality control by monitoring accuracy andprecision for the quantitative methods as specifiedUnchangedin the enclosed value sheet.</td><td colspan="1" rowspan="1">Unchaged</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Vial (liquid)2 levels : Low / HighHuman urine with added constituents of humanand animal origin, chemicals, preservatives andstabilizers.</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Liquid, ready to use</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">Horiba Medical specific label</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Notice</td><td colspan="1" rowspan="1">Horiba Medical specific notice</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Kit composed of :1 x 10 ml Low Control1 x 10 ml High Control</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Performance data :Theoretical values andconfidence intervals</td><td colspan="1" rowspan="1">- The assigned values are determined bycalculating the median value obtained frommultiple determinations.- The assigned values for both Low and Highcontrols are lot specific- The assigned values and precise confidenceinterval are indicated in the annex enclosed in the</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">MY</td><td colspan="1" rowspan="1">kit</td><td colspan="1" rowspan="1">EP</td></tr><tr><td colspan="1" rowspan="1">Closed stability</td><td colspan="1" rowspan="1">2 years at 2-8°C</td><td colspan="1" rowspan="1">Unchanged</td></tr><tr><td colspan="1" rowspan="1">Open stability</td><td colspan="1" rowspan="1">30 days at 2-8°C</td><td colspan="1" rowspan="1">Unchanged</td></tr></table>

# Differences :

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Predicate device (K070249):</td><td rowspan=1 colspan=1>Device :</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>ABX Pentra Urine Control L/H</td><td rowspan=1 colspan=1>ABX Pentra UrineControl L/H</td></tr><tr><td rowspan=1 colspan=1>Controlled molecules</td><td rowspan=1 colspan=1>The exact control values are givenin the enclosed annex</td><td rowspan=1 colspan=1>Updated to includenew applicationvalues for newarsenazo calcium</td></tr><tr><td rowspan=1 colspan=1>Controlled molecules :</td><td rowspan=1 colspan=1>Applications cleared :</td><td rowspan=1 colspan=1>Application notcleared under thissubmission:</td></tr><tr><td rowspan=1 colspan=1>Amylase, Calcium, Phosphorus,Glucose HK, Urea/BUN, Uric Acid,Total Proteins (Urinary), Creatinine120, Enzymatic Creatinine, NewArsenazo Calcium</td><td rowspan=1 colspan=1>K070249, K070249, K070249,K070146, K070146, K070146,K070146, K072115, K110137K110530, -</td><td rowspan=1 colspan=1>New ArsenazoCalcium Applicationnot cleared (in thissubmission)</td></tr><tr><td rowspan=1 colspan=1>Value sheet / Annex</td><td rowspan=1 colspan=1>Horiba Medical specific annex</td><td rowspan=1 colspan=1>New Horiba Medicalspecific annex</td></tr></table>

# C. Description:

All the reagent, controls and calibrator included in this submission are for use on the ABX PENTRA 400 (K052007), which is a discrete photometric benchtop clinical chemistry analyzer.

The ABX Pentra Calcium AS CP is an in vitro diagnostic assay for the quantitative in vitro determination of calcium in human serum, plasma and urine based on colourimetric method. It is composed of a monoreagent cassette $( 7 9 { \mathrm { m L } } )$ . The reagent is chemical solution with additives..

The ABX PENTRA Multical is a lyophilized human serum calibrator with chemical additives and materials of biological origin. The assigned values of the calibrator components are given in the enclosed annex, ensuring optimal calibration of the appropriate HORIBA ABX SAS methods on the ABX PENTRA 400 analyzer.

This calibrator is provided in ten vials of $3 ~ \mathrm { m l }$

The ABX PENTRA N Control and ABX PENTRA P Control are quality control products consisting of lyophilized human serum with chemical additives and materials of biological origin added as required to obtain given component levels. The assigned values of the control components are given in the enclosed annexes, ensuring control of the appropriate HORIBA

ABX SAS methods on the ABX PENTRA 400 analyzer. Each control is provided in ten vials of 5 ml.

The ABX PENTRA Urine Control L/H is a two-level (Low and High) quality control consisting of liquid solutions prepared from human urine with chemical additives and materials of biological origin added as required to obtain given component levels. The assigned values of the control components are given in the enclosed annex, ensuring control of the appropriate HORIBA ABX SAS methods on the ABX PENTRA 400 analyzer. Each control level is provided in one vial of $1 0 ~ \mathrm { m l }$ .

# D. Intended Use:

The reagent in this submission is intended for use on the ABX PENTRA 400.

The controls and calibrator are intended for use in association with the above reagent on the ABX PENTRA 400.

# Indications for use:

ABX Pentra Calcium AS CP reagent, with associated calibrator and controls, is a diagnostic reagent for quantitative in vitro determination of calcium in human serum, plasma and urine based on a colourimetric method, using the ABX Pentra 400 Clinical Chemistry analyzer. Measurement of calcium is used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

The ABX PENTRA Multical is a calibrator for use in the calibration of quantitative Horiba Medical methods on Horiba Medical clinical chemistry analyzers. The ABX PENTRA N Control is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers. The ABX PENTRA P Control is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers. The ABX PENTRA Urine Control L/H is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers.

# E. Discussion of nonclinical tests submitted:

All the performance studies were conducted using the ABX Pentra 400 clinical chemistry analyzer.

1. Detection limit

The detection limits are determined according to CLSI (NCCLS), EP17-A protocol: Protocols for determination of limits of detection and limits of quantitation. Approved Guideline, CLSI (NCCLS) document EP17-A (2004) 24 (34).   
Serum/Plasma : $0 . 2 8 \mathrm { m g / d l }$ EY   
Urine : 0.23 mg/dl

Limit of quantitation

The limits of quantitation are determined according to CLSI (NCCLS), EP17-A protocol: Protocols for determination of limits of detection and limits of quantitation. Approved Guideline, CLSI (NCCLS) document EP17-A (2004) 24 (34).   
Serum/Plasma : 1.54 mg/dl   
Urine : 0.64 mg/dl

3Repeatability (within-run precision)

3 specimens of low, medium and high concentration and 2 controls are tested 20 times according to the recommendations found in the Valtec protocol : Vassault A, Grafmeyer $D ,$ Naudin $C$ et al. Protocole de validation de techniques (document B). Ann. Biol. Clin. (1986) 44: 686-745.

For serum/plasma   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean value (mg/dl)</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>Control specimen 1</td><td rowspan=1 colspan=1>8.39</td><td rowspan=1 colspan=1>0.49</td></tr><tr><td rowspan=1 colspan=1>Control specimen 2</td><td rowspan=1 colspan=1>12.53</td><td rowspan=1 colspan=1>0.37</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>6.91</td><td rowspan=1 colspan=1>0.71</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>9.18</td><td rowspan=1 colspan=1>0.40</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>13.15</td><td rowspan=1 colspan=1>0.43</td></tr></table>

For urine   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean value (mg/dl)</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>Control specimen 1</td><td rowspan=1 colspan=1>7.27</td><td rowspan=1 colspan=1>0.62</td></tr><tr><td rowspan=1 colspan=1>Control specimen 2</td><td rowspan=1 colspan=1>10.86</td><td rowspan=1 colspan=1>0.76</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>7.73</td><td rowspan=1 colspan=1>0.46</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>10.50</td><td rowspan=1 colspan=1>0.56</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>14.50</td><td rowspan=1 colspan=1>0.37</td></tr></table>

# Reproductibility (total precision)

3 specimens of low, medium and high levels and 2 controls are tested in duplicate for 20 days (2 series per day) according to the recommendations found in the CLSI (NCCLS),

EP5-A2 protocol : Evaluation of Precision Performance of Quantitative Measurement Method. Approved Guideline, CLSI (NCCLS) document EP5-A2 (2004) 24 (25).   
For serum/plasma   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean value (mg/dl)</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>Control specimen 1</td><td rowspan=1 colspan=1>8.72</td><td rowspan=1 colspan=1>1.44</td></tr><tr><td rowspan=1 colspan=1>Control specimen 2</td><td rowspan=1 colspan=1>13.02</td><td rowspan=1 colspan=1>1.49</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>7.03</td><td rowspan=1 colspan=1>1.56</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>9.47</td><td rowspan=1 colspan=1>1.54</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>12.93</td><td rowspan=1 colspan=1>1.54</td></tr></table>

For urine   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean value (mg/dl)</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>Control specimen 1</td><td rowspan=1 colspan=1>7.28</td><td rowspan=1 colspan=1>1.45</td></tr><tr><td rowspan=1 colspan=1>Control specimen 2</td><td rowspan=1 colspan=1>10.71</td><td rowspan=1 colspan=1>1.50</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>7.70</td><td rowspan=1 colspan=1>1.57</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>10.27</td><td rowspan=1 colspan=1>1.57</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>14.21</td><td rowspan=1 colspan=1>1.56</td></tr></table>

# 5Measuring range

The assay confirmed a measuring range from $4 . 0 ~ \mathrm { { \ m g / d l } ~ - ~ 1 8 . 0 5 ~ \mathrm { { \ m g / d l } } }$ (for serum/plasma) and $0 . 6 4 ~ \mathrm { m g / d l } ~ - 1 8 . 0 5 ~ \mathrm { m g / d l }$ (for urine), with an automatic post-dilution up to $5 4 . 1 5 ~ \mathrm { m g / d l }$ .

According to the recommendations found in the CLSI (NCCLS), EP6-A protocol : Evaluation of the Linearity of Quantitative Analytical Methods. Approved Guideline, CLSI (NCCLS) document EP6-A (2003) 23 (16), the reagent linearity for serum/plasma and urine has been assessed up to $1 8 . 0 5 ~ \mathrm { m g / d } 1$ , and with automatic post-dilution : 54.15 $\mathrm { m g / d l }$ .

Method comparison

According to the recommendations found in the CLSI (NCCLS), EP9-A2 protocol: Method Comparison and Bias Estimation Using Patient Samples. Approved Guideline, 2nd ed., CLSI (NCCLS) document EP9-A2 (2002) 22 (19), patient samples $[ \mathfrak { n } { = } 1 4 5$ for serum/plasma; $\mathrm { \tt n } { = } 1 4 3$ for urine) are correlated with a commercial reagent taken as reference.

Values ranged from $4 . 1 7 \mathrm { m g / d l }$ to $1 5 . 7 6 ~ \mathrm { m g / d l }$ for serum/plasma and $0 . 6 4 ~ \mathrm { m g / d l }$ to 17.80 $\mathfrak { m g } / \mathrm { d } \mathrm { ! }$ for urine.

The equations for the allometric line obtained using Passing- Bablock regression procedure: Passing H, Bablock W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J. Clin. Chem. Clin. Biochem. (1983) 21: 709-20., are:   
For serum/plasma: $\mathrm { Y } = \mathrm { 1 . 0 0 ~ x } + 0 . 0 4 \left( \mathrm { m g } / \mathrm { d l } \right)$ with ${ \mathfrak { r } } ^ { 2 } = 0 . 9 9 0 3$   
For urine: $\mathbf { Y } = 0 . 9 8 ~ \mathbf { x } - 0 . 0 3$ $( \mathrm { m g / d l } )$ with $\mathrm { r } ^ { 2 } = 0 . 9 9 3$ E

7. Matrix comparison study

A matrix comparison study between serum and lithium plasma samples was performed using 32 paired serum and lithium plasma samples, ranging in calcium concentration from $4 . 0 \ \mathrm { m g / d L }$ to $1 7 . 5 ~ \mathrm { m g / d L }$ (3 samples were altered). Each sample was tested in singulate using the ABX Pentra Calcium AS CP assay reagent. Linear regression analysis of the plot of serum (x-axis) and lithium plasma (y-axis) samples showed the following relationships between the matrix types: $\mathbf { y } = 1 . 0 0 6 \mathbf { x } - 0 . 0 0 2 2$ $\Gamma ^ { 2 } = 0 . 9 9 6$

8. Calibration stability

Thereagen s calbratedn ay Te clbatistabiliy sceckd by t control specimens.

The calibration stability is 10 days for serum/plasma and urine.

A recalibration is recommended when reagent lots change, and when quality control results fall outside the range established.

Reagent stability

Closed stability: 24 months at $2 { - } 8 ^ { \circ } C$ On-board stability: 60 days at $2 { - } 8 ^ { \circ } \mathrm { C }$

# F. CALIBRATOR

<table><tr><td colspan="4" rowspan="1">ABX PENTRA Multical:</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="2" rowspan="1">Already cleared(K052007, K060205, K060318,K060325, K060854, K062180,K062737, K060434, K072115,K110137, K110530)</td><td colspan="1" rowspan="1">Included in this submission</td></tr><tr><td colspan="1" rowspan="1">Alkaline phosphatase</td><td colspan="2" rowspan="1">√</td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Alanine aminotransferase</td><td colspan="2" rowspan="1">√</td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Amylase</td><td colspan="2" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Aspartate aminotransferase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Creatine kinase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">GGT</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">.</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">LDH</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v.</td></tr><tr><td colspan="1" rowspan="1">Lipase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Y</td></tr><tr><td colspan="1" rowspan="1">Direct Bilirubin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Bilirubin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Calcium</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">New Calcium AS</td><td colspan="2" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Y</td></tr><tr><td colspan="1" rowspan="1">Creatinine 120</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Enzymatic Creatinine CP</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√.</td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Glucose HK</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Glucose PAP</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Iron</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Lactic acid</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√.</td></tr><tr><td colspan="1" rowspan="1">Magnesium</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Phosphorus</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Total Protein</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Protein 100</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Urea / Blood Urea Nitrogen</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Uric acid</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">FormatStability</td><td colspan="3" rowspan="1">Lyophilized human serum with chemical additives and materialsof biological originClosed stability: 24 months at 2-8°COpen stability:Once opened, the calibrator components** are stable for :8 hours at 15°C to 25°C2 days at 2°C to 8°C2 weeks at -25°C to -15°C**ExceptionsDirect Bilirubin3 hours at 15°C to 25°C8 hours at 2°C to 8°C2 weeks at -25°C to -15°C                                ../...Total Bilirubin6 hours at 15°C to 25°C1 day at 2°C to 8°C2 weeks at 25°C to -15°C</td></tr></table>

# G. CONTROLS

<table><tr><td rowspan=1 colspan=4>ABX PENTRA N Control:</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=2>Already cleared(K052007, K060205, K060318,K060325, K060854, K062180,K062737, K060434, K072115,K110137, K110530)</td><td rowspan=1 colspan=1>Included in this submission</td></tr><tr><td rowspan=1 colspan=1>Alkaline phosphatase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Alanine aminotransferase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Amylase</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√.</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Aspartate aminotransferase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Creatine kinase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>GGT</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>v</td></tr><tr><td rowspan=1 colspan=1>LDH</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>cYanmaYelob</td><td rowspan=1 colspan=1>√</td></tr></table>

# ABX PENTRA N Control:

<table><tr><td colspan="4" rowspan="1">ADIMInT  coltrol:</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Direct Bilirubin</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Bilirubin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Calcium</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">New Calcium AS</td><td colspan="2" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Chloride</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">HDL</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">\</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">LDL</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Creatinine 120</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Enzymatic Creatinine CP</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Glucose HK</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Glucose PAP</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Iron</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Lactic acid</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Magnesium</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Phosphorus</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Protein</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Protein 100</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">cYanmaGaYellowb</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Urea / Blood Urea Nitrogen</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Uric acid</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1"></td><td></td><td></td><td></td></tr><tr><td colspan="1" rowspan="1">FormatStability</td><td colspan="3" rowspan="1">Lyophilized human serum with chemical additives and materialsof biological originClosed stability: 30 months at 2-8°COpen stability:Once opened, the control components** are stable for :12 hours at 15°C to 25°C5 days at 2°C to 8°C1 month at 25°C to -15°C**ExceptionsDirect Bilirubin4 hours at 15°C to 25°C8 hours at 2°C to 8°C2 weeks at 25°C to -15°CTotal Bilirubin8 hours at 15°C to 25°C1 day at 2°C to 8°2 weeks at 25°C to -15°C</td></tr><tr><td colspan="4" rowspan="1">ABX PENTRA P Control:</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="2" rowspan="1">Already cleared(K052007, K060205, K060318,K060325, K060854, K062180,K062737, K060434, K072115,K110137, K110530)</td><td colspan="1" rowspan="1">Included in this submission</td></tr><tr><td colspan="1" rowspan="1">Alkaline phosphatase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Alanine aminotransferase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Amylase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Aspartate aminotransferase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Creatine kinase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">GGT</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">LDH</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Lipase</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Albumin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√.</td></tr><tr><td colspan="1" rowspan="1">Direct Bilirubin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Bilirubin</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Calcium</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">New Calcium AS</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Chloride</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">HDL</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">LDL</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Creatinine 120</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Enzymatic Creatinine CP</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Glucose HK</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Glucose PAP</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Iron</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Lactic acid</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Magnesium</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Phosphorus</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Protein</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Total Protein 100</td><td colspan="1" rowspan="1">V</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">V</td></tr><tr><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">v</td></tr><tr><td colspan="1" rowspan="1">Urea / Blood Urea Nitrogen</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">Uric acid</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">Y</td><td colspan="1" rowspan="1">√</td></tr><tr><td colspan="1" rowspan="1">FormatStability</td><td colspan="3" rowspan="1">Lyophilized human serum with chemical additives and materialsof biological originClosed stability: 30 months at 2-8°COpen stability:Once opened, the control components** are stable for :12 hours at 15°C to 25°5 days at 2°C to 8°C</td></tr></table>

<table><tr><td colspan="2">ABX PENTRA P Control:</td></tr><tr><td>Total Bilirubin</td><td>1 month at -25°C to -15°C **Exceptions Direct Bilirubin 4 hours at 15°C to 25°C</td></tr></table>

<table><tr><td rowspan=1 colspan=3>ABX PENTRA Urine Control L/H:</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Already cleared (K07249,K072115, K110137, K110530)</td><td rowspan=1 colspan=1>Included in this submission</td></tr><tr><td rowspan=1 colspan=1>Amylase</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Calcium</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>New Calcium AS</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Creatinine 120</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Enzymatic Creatinine CP</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>Urea / Blood Urea Nitrogen</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>v</td></tr><tr><td rowspan=1 colspan=1>Uric acid</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>v.</td></tr><tr><td rowspan=1 colspan=1>Urinary proteins</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>FormatStability</td><td rowspan=1 colspan=2>Liquid solution prepared from human urine with chemicaladditives and materials of biological originClosed stability: 2 years at 2-8°COpen stability: 30 days at 2-8°C</td></tr></table>

# Conclusions for Performance Testing:

The performance testing data conclude that the safety and effectiveness of the devices are not compromised, and that they met all acceptance criteria, demonstrating that the devices are substantially equivalent to their respective predicate devices.

Horiba ABX SAS C/O Caroline Ferrer Parc Euromédecine Rue du Caducée - BP 7290 34184 Montpellier cedex 4 FRANCE

Re: K123171 Trade/Device Name: ABX PENTRA CALCIUM AS CP, ABX PENTRA Multical, ABX PENTRA N Control, ABX PENTRA P Control, ABX PENTRA Urine Control L/H

Regulation Number: 21 CFR 862.1145   
Regulation Name: Calcium test system   
Regulatory Class: II   
Product Code: CJY, JIX, JY   
Dated: May 17, 2013   
Received: May 20, 2013

Dear Ms. Ferrer:

We have reviewed your Section $\mathsf { S l o } ( \mathbf { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Pait 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucmlIS809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Carol C. Benson -S for

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

# Indications for Use Form

510(k) Number (if known): k123171

Device Name: ABX Pentra Calcium AS CP

Indications for Use:

ABX Pentra Calcium AS CP reagent, with associated calibrator and controls, is a diagnostic reagent for quantitative in vitro determination of calcium in human serum, plasma and urine based on a colourimetric method, using the ABX Pentra 400 Clinical Chemistry analyzer. Measurement of calcium is used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

# Indication for Use Form

510(k) Number (if known): k123171

Device Name: ABX PENTRA Multical

Indications for Use:

The ABX PENTRA Multical is a calibrator for use in the calibration of quantitative Horiba Medical methods on Horiba Medical clinical chemistry analyzers.

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR) Yung W. Chan -S

Division Sign-Off Office of In Vitro Diagnostics and Radiological Health

# Indication for Use Form

510(k) Number (if known): k123171

Device Name: ABX PENTRA N Control

Indications for Use:

The ABX PENTRA N Control is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

# Indication for Use Form

510(k) Number (if known): k123171

Device Name: ABX PENTRA P Control

Indications for Use:

The ABX PENTRA P Control is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers.

# Indication for Use Form

510(k) Number (if known): k123171

Device Name: ABX PENTRA Urine Control L/H .

Indications for Use:

The ABX PENTRA Urine Control L/H is for use in quality control by monitoring accuracy and precision of Horiba Medical methods on Horiba Medical clinical chemistry analyzers.

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)